Biotin-dependent regulation of gene expression in human cells

The role of biotin as cofactor of carboxylases and its importance in metabolic homeostasis are well known. In recent years, different researchers have suggested the participation of biotin as a regulator molecule in the control of gene expression. Biotin-dependent gene expression requires of the transformation of biotin into biotinyl-5'-AMP by holocarboxylase synthetase and the activation of soluble guanylate cyclase and a cGMP-dependent protein kinase. The regulatory role of biotin is responsible for the correct expression of enzymes involved in biotin utilization in human cells. We propose that this mechanism protects the brain from biotin deficiency.     

转录后水平沉默与基因表达

基因沉默是1个非常复杂和普遍的现象。转录后水平的基因沉默是指转基因在细胞核里能稳定转录,细胞质里却无相应的稳定态mRNA存在的现象。它往往被称为共抑制、静息作用或RNA干预等。本文介绍了转录后水平的基因沉默现象的发现、分子机理和应用等方面的进展。提出了克服转录后水平基因沉默的一些对策。     

Transcriptional Regulation of Urokinase Receptor in High-（95D） and Low-metastatic （95C） Human Lung Cancer Cells

The malignant neoplasm is characterized by progres-sive growth and the ability to disseminate tumor cellsbeyond the boundaries of the parent tumor. Tumor in-vasion and metastasis are important aspects of tumorprogression and the formation of tumor and metastasis is aprincipal contributing factor to cancer morbidity andmortality. During this process urokinase (urokinase-typeplasminogen activator, uPA) and its receptor (uPAR) playan important role. uPAR is a 55–60 kD glycoprotein which is a…     

Insulin receptor regulation in human mature red cells in vitro

We have studied the ability of mature red cells to regulate the number and affinity of their insulin receptors, in vitro. Our data show that mature red cells are not able to change either the number and the affinity of their insulin receptors, after preincubation with high concentrations of insulin alone or insulin and glucose. We conclude that mature red cells possess an insulin receptor system not completely similar to that of major target cells such as hepatocytes and adipocytes, and therefore we suggest some criticism in evaluating these cells in clinical studies, regarding the insulin receptor status.